Graham Capital Management LP Has Cut Its Valeant Pharmaceuticals Intl (Put) (VRX) Position by $4.00 Million; Shares Declined; Two Sigma Securities Has Decreased Position in Mondelez Intl (MDLZ) by $315,924

May 23, 2018 - By Ash

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) Logo

Two Sigma Securities Llc decreased its stake in Mondelez Intl Inc (MDLZ) by 44.67% based on its latest 2017Q4 regulatory filing with the SEC. Two Sigma Securities Llc sold 7,522 shares as the company’s stock declined 5.65% with the market. The hedge fund held 9,316 shares of the consumer non-durables company at the end of 2017Q4, valued at $399,000, down from 16,838 at the end of the previous reported quarter. Two Sigma Securities Llc who had been investing in Mondelez Intl Inc for a number of months, seems to be less bullish one the $58.29B market cap company. The stock increased 0.22% or $0.08 during the last trading session, reaching $39.51. About 2.93M shares traded. Mondelez International, Inc. (NASDAQ:MDLZ) has declined 6.02% since May 23, 2017 and is downtrending. It has underperformed by 17.57% the S&P500.

Kenneth Tropin decreased its stake in Valeant Pharmaceuticals Intl (Put) (VRX) by 66.67% based on its latest 2017Q4 regulatory filing with the SEC. Graham Capital Management Lp sold 200,000 shares as the company’s stock declined 28.77% with the market. The hedge fund run by Kenneth Tropin held 100,000 shares of the health care company at the end of 2017Q4, valued at $2.08M, down from 300,000 at the end of the previous reported quarter. Graham Capital Management Lp who had been investing in Valeant Pharmaceuticals Intl (Put) for a number of months, seems to be less bullish one the $7.65B market cap company. The stock decreased 0.54% or $0.12 during the last trading session, reaching $21.91. About 3.43 million shares traded. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has risen 42.00% since May 23, 2017 and is uptrending. It has outperformed by 30.45% the S&P500.

More notable recent Valeant Pharmaceuticals International, Inc. (NYSE:VRX) news were published by: Seekingalpha.com which released: “Valeant Is Growing Once More” on May 10, 2018, also Benzinga.com with their article: “Steve Sosnick’s Valeant Options Trade” published on May 04, 2018, Seekingalpha.com published: “Assessing The AMD Battleground From All Sides” on May 23, 2018. More interesting news about Valeant Pharmaceuticals International, Inc. (NYSE:VRX) were released by: Seekingalpha.com and their article: “Valeant Pharmaceuticals Can Still Go Higher – Cramer’s Lightning Round (5/21/18)” published on May 22, 2018 as well as Seekingalpha.com‘s news article titled: “Tracking Jeffrey Ubben’s ValueAct Portfolio – Q1 2018 Update” with publication date: May 22, 2018.

Since March 8, 2018, it had 4 buys, and 0 insider sales for $1.20 million activity. $481,500 worth of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) was bought by PAPA JOSEPH C on Tuesday, March 13. The insider Herendeen Paul bought 15,000 shares worth $241,470.

Analysts await Valeant Pharmaceuticals International, Inc. (NYSE:VRX) to report earnings on August, 14. They expect $0.78 earnings per share, down 25.71% or $0.27 from last year’s $1.05 per share. VRX’s profit will be $272.45 million for 7.02 P/E if the $0.78 EPS becomes a reality. After $0.89 actual earnings per share reported by Valeant Pharmaceuticals International, Inc. for the previous quarter, Wall Street now forecasts -12.36% negative EPS growth.

Among 28 analysts covering Valeant Pharmaceuticals Intl (NYSE:VRX), 8 have Buy rating, 5 Sell and 15 Hold. Therefore 29% are positive. Valeant Pharmaceuticals Intl had 169 analyst reports since July 21, 2015 according to SRatingsIntel. The company was maintained on Friday, November 6 by Guggenheim. Nomura initiated the shares of VRX in report on Tuesday, September 29 with “Buy” rating. The company was maintained on Tuesday, October 3 by Canaccord Genuity. The stock has “Hold” rating by Deutsche Bank on Tuesday, September 20. As per Thursday, June 29, the company rating was maintained by Stifel Nicolaus. BMO Capital Markets maintained the shares of VRX in report on Friday, September 29 with “Hold” rating. As per Thursday, March 23, the company rating was maintained by RBC Capital Markets. Morgan Stanley downgraded the shares of VRX in report on Thursday, December 15 to “Equal-Weight” rating. The stock has “Neutral” rating by BTIG Research on Thursday, May 11. The firm has “Neutral” rating given on Monday, August 15 by Mizuho.

Graham Capital Management Lp, which manages about $16.17B and $3.84 billion US Long portfolio, upped its stake in Ak Stl Corp by 564,000 shares to 64.62M shares, valued at $85.48M in 2017Q4, according to the filing. It also increased its holding in Lee Enterprises Inc (NYSE:LEE) by 365,000 shares in the quarter, for a total of 916,128 shares, and has risen its stake in Ishares Inc (EWZ).

Investors sentiment decreased to 0.97 in 2017 Q4. Its down 0.02, from 0.99 in 2017Q3. It is negative, as 51 investors sold VRX shares while 74 reduced holdings. 54 funds opened positions while 67 raised stakes. 169.66 million shares or 0.12% less from 169.87 million shares in 2017Q3 were reported. Quantbot Technologies LP reported 0.08% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Vertex One Asset Mngmt invested 2.27% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Amundi Pioneer Asset Management, Massachusetts-based fund reported 89,191 shares. Sei Invs holds 0% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX) for 2,753 shares. D E Shaw & Communication has invested 0.02% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Gabelli Funds Ltd Liability Corporation has invested 0.01% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Stratos Wealth Partners Ltd reported 0% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Deutsche Comml Bank Ag invested in 2.85M shares. Prudential Public Ltd Co invested in 0.02% or 290,714 shares. Td Asset Mngmt Inc holds 1.13M shares. Jefferies Gp Ltd reported 0.07% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Parametric Port Assocs Ltd Liability Co accumulated 1.29 million shares. Canada Pension Plan Board owns 112,306 shares or 0% of their US portfolio. Saba Cap Ltd Partnership reported 104,759 shares. Bnp Paribas Arbitrage holds 0% or 70,687 shares.

Among 23 analysts covering Mondelez International Inc (NASDAQ:MDLZ), 18 have Buy rating, 1 Sell and 4 Hold. Therefore 78% are positive. Mondelez International Inc had 66 analyst reports since July 31, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets on Friday, July 31 with “Outperform”. The stock of Mondelez International, Inc. (NASDAQ:MDLZ) earned “Buy” rating by BMO Capital Markets on Wednesday, September 6. BMO Capital Markets maintained Mondelez International, Inc. (NASDAQ:MDLZ) rating on Wednesday, June 14. BMO Capital Markets has “Buy” rating and $4800 target. As per Monday, October 26, the company rating was maintained by RBC Capital Markets. The firm has “Buy” rating given on Thursday, February 1 by BMO Capital Markets. The company was maintained on Monday, September 18 by Stifel Nicolaus. The firm earned “Buy” rating on Wednesday, January 31 by Piper Jaffray. The rating was upgraded by Goldman Sachs on Tuesday, April 4 to “Buy”. Morgan Stanley maintained Mondelez International, Inc. (NASDAQ:MDLZ) rating on Thursday, February 1. Morgan Stanley has “Overweight” rating and $50 target. The stock of Mondelez International, Inc. (NASDAQ:MDLZ) earned “Buy” rating by Piper Jaffray on Monday, September 18.

Since February 16, 2018, it had 2 insider buys, and 3 selling transactions for $1.03 billion activity. PELTZ NELSON also sold $284.87M worth of Mondelez International, Inc. (NASDAQ:MDLZ) shares. MAY PETER W also sold $793.31 million worth of Mondelez International, Inc. (NASDAQ:MDLZ) on Tuesday, March 6. 10,931 shares valued at $478,668 were sold by Weber Hubert on Thursday, February 22.

Analysts await Mondelez International, Inc. (NASDAQ:MDLZ) to report earnings on August, 1. They expect $0.54 earnings per share, up 12.50% or $0.06 from last year’s $0.48 per share. MDLZ’s profit will be $796.63 million for 18.29 P/E if the $0.54 EPS becomes a reality. After $0.62 actual earnings per share reported by Mondelez International, Inc. for the previous quarter, Wall Street now forecasts -12.90% negative EPS growth.

Two Sigma Securities Llc, which manages about $3.73B US Long portfolio, upped its stake in Procter And Gamble Co (Call) (NYSE:PG) by 124,142 shares to 128,200 shares, valued at $11.78M in 2017Q4, according to the filing. It also increased its holding in Netease Inc (Put) (NASDAQ:NTES) by 5,900 shares in the quarter, for a total of 9,900 shares, and has risen its stake in Applied Matls Inc (Put) (NASDAQ:AMAT).

Investors sentiment increased to 1 in 2017 Q4. Its up 0.16, from 0.84 in 2017Q3. It is positive, as 56 investors sold MDLZ shares while 388 reduced holdings. 107 funds opened positions while 338 raised stakes. 1.07 billion shares or 1.13% less from 1.08 billion shares in 2017Q3 were reported. Tci Wealth Advsrs Inc reported 7,766 shares or 0.15% of all its holdings. Texas-based Moody Bank & Trust Trust Division has invested 0.07% in Mondelez International, Inc. (NASDAQ:MDLZ). Tarbox Family Office has 0.05% invested in Mondelez International, Inc. (NASDAQ:MDLZ). Horan Capital Advsrs Ltd Liability holds 1.19% or 42,627 shares in its portfolio. Atria Investments Limited Liability Corporation owns 12,388 shares. Liberty Mutual Asset Incorporated holds 0.08% of its portfolio in Mondelez International, Inc. (NASDAQ:MDLZ) for 60,089 shares. Nbt Commercial Bank N A Ny has invested 0.22% in Mondelez International, Inc. (NASDAQ:MDLZ). Atlanta Capital L L C, Georgia-based fund reported 1.68M shares. 104,298 are held by Walleye Trading Limited Liability. Moreover, Markston Limited Liability has 0.37% invested in Mondelez International, Inc. (NASDAQ:MDLZ). Livforsakringsbolaget Skandia Omsesidigt invested 0.09% of its portfolio in Mondelez International, Inc. (NASDAQ:MDLZ). Field Main Bank & Trust accumulated 10,485 shares or 0.43% of the stock. Mitsubishi Ufj Hldg Co Ltd holds 650 shares. Jnba Advsrs reported 558 shares. The New York-based Gotham Asset Mngmt Limited Liability has invested 0.08% in Mondelez International, Inc. (NASDAQ:MDLZ).

More notable recent Mondelez International, Inc. (NASDAQ:MDLZ) news were published by: Globenewswire.com which released: “MondelÄ“z International Reports Q1 Results” on May 01, 2018, also Streetinsider.com with their article: “GlaxoSmithKline (GSK) Indian Consumer Unit Receives Frenzy of Interest – Economic Times” published on May 23, 2018, Globenewswire.com published: “Public-Private Partnerships Are Key To Addressing Childhood Obesity” on May 14, 2018. More interesting news about Mondelez International, Inc. (NASDAQ:MDLZ) were released by: Globenewswire.com and their article: “MondelÄ“z International Names Paulette Alviti Chief Human Resources Officer” published on April 27, 2018 as well as Globenewswire.com‘s news article titled: “MondelÄ“z International to Acquire Tate’s Bake Shop” with publication date: May 07, 2018.

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.